Castle Rock Wealth Management’s Medpace MEDP Stock Holding History

Castle Rock Wealth Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,381	Closed	-$216K	–	237
2022 Q1	$216K	Sell	1,381 -672	-33%	-$111K	0.1%	215
2021 Q4	$338K	Sell	2,053 -401	-16%	-$84K	0.14%	177
2021 Q3	$551K	Buy	2,454 +345	+16%	+$62.9K	0.19%	144
2021 Q2	$365K	Sell	2,109 -125	-6%	-$21.6K	0.13%	183
2021 Q1	$419K	Buy	2,234 +132	+6%	+$20.2K	0.17%	172
2020 Q4	$298K	Buy	+2,102	New	+$265K	0.12%	197
2020 Q1	–	Sell	-2,341	Closed	-$227K	–	163
2019 Q4	$227K	Buy	+2,341	New	+$181K	0.2%	145
2019 Q3	–	Sell	-3,827	Closed	-$254K	–	174
2019 Q2	$254K	Buy	+3,827	New	+$221K	0.28%	111

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

ESCM

Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Castle Rock Wealth Management's MEDP Position: Q2 2022 in Review

Castle Rock Wealth Management sold out of Medpace (MEDP) in Q2 2022, closing a stake of 1,381 shares — an estimated $216K sold.

Castle Rock Wealth Management first reported a position in MEDP in Q2 2019 and held it in 8 quarters. The position peaked at $551K in Q3 2021. 340 funds tracked by Wall St. Rank hold MEDP as of Q2 2022.

Castle Rock Wealth Management reported no remaining Medpace position as of Q2 2022 after selling out during the quarter.
Castle Rock Wealth Management sold 1,381 Medpace shares in Q2 2022, an estimated $216K.
Castle Rock Wealth Management first reported a position in Medpace in Q2 2019 and held it in 8 quarters.
Castle Rock Wealth Management's Medpace position peaked at $551K in Q3 2021.
340 funds tracked by Wall St. Rank held Medpace as of Q2 2022.

Based on Castle Rock Wealth Management's 13F filing for Q2 2022, filed 13 Jul 2022.